#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Prostate cancer Systemic scleroderma Laryngeal squamous cell carcinoma Squamous cell carcinoma of the oral cavity Congenital megacolon Heavy menstrual bleeding Behcet's syndrome Pyoderma gangrenosum Neuroendocrine carcinoma metastatic Mucopolysaccharidosis II Autoimmune haemolytic anaemia Encephalitis autoimmune Sexually transmitted disease Mycobacterium abscessus infection Pleomorphic leiomyosarcoma More trials…

    Learn about Rare Diseases

    Mucopolysaccharidosis – Trials in Disease Leiomyosarcoma recurrent – Diagnostics Splenic marginal zone lymphoma Chordoma – Diagnostics Behcet’s syndrome – Trials in Disease Short-bowel syndrome – Trials in Disease Prolymphocytic leukaemia – Treatment Idiopathic inflammatory myopathy – Treatment Antisynthetase syndrome – Treatment Combined immunodeficiency More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Evolocumab Aticaprant Clemizole Hydrochloride Nnc0194-0499 TETANUS TOXOID Axicabtagene Ciloleucel Romosozumab Mycophenolate Sodium Erenumab FLUCLOXACILLIN SODIUM Ep262 Kan-101 Povetacicept Rotigotine Sumatriptan Succinate LIPASE Sodium Iodide Dazodalibep RP3 Vibostolimab More therapies…

    Learn about Your Condition

    Tendon disorder Vomiting Precocious puberty Ovarian cancer Ehlers-Danlos syndrome Atrial flutter Non-obstructive cardiomyopathy Osteomyelitis Tachypnoea Gastric cancer recurrent Procedural hypotension Complex regional pain syndrome Chronic sinusitis Trigeminal neuralgia Bone sarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of Remdesivir to Prevent Severe COVID-19 in Kidney Transplant Recipients with No or Mild Symptoms

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • COVID-19
    Investigated Drugs:
    • Remdesivir
    Spain

  • Study of sublingual immunotherapy with Dermatophagoides pteronyssinus and Dermatophagoides farinae allergen mix for patients with dust mite allergic rhinitis

    Recruiting

    2 1
    Investigated Diseases:
    • Conjunctivitis
    • Rhinitis allergic
    Investigated Drugs:
    • Dermatophagoides Farinae
    • Dermatophagoides Pteronyssinus
    • Sodium Chloride
    Spain

  • Study of gene-modified stem cells (FT024) in children with TCIRG1-related osteopetrosis using treosulfan, thiotepa, and plerixafor for treatment

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • AUTOLOGOUS HAEMATOPOIETIC STEM AND PROGENITOR CELL POPULATION CONTAINING CD34+ CELLS TRANSDUCED WITH A LENTIVIRAL VECTOR ENCODING THE TCIRG1 CDNA EX VIVO EXPANDED
    • Plerixafor
    • Thiotepa
    Italy

  • Study of MK-2214 to slow disease progression in people with early Alzheimer’s disease

    Recruiting

    2 1
    Investigated Drugs:
    • Florquinitau (18F)
    Belgium The Netherlands Spain

  • Testing the safety of stopping riociguat in patients with chronic thromboembolic pulmonary hypertension after successful balloon pulmonary angioplasty treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pulmonary hypertension
    Investigated Drugs:
    • Riociguat
    The Netherlands

  • Evaluating intraperitoneal irinotecan with systemic therapy in patients with gastric peritoneal metastases

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Metastatic gastric cancer
    Investigated Drugs:
    • Irinotecan Hydrochloride Trihydrate
    The Netherlands
Previous Page
1 … 145 146 147 148 149 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!